AMZN
Amazon.com, Inc.
AMZN has the edge over CVGI overall, supported by lower modeled downside and stronger valuation.
CVGI
Commercial Vehicle Group, Inc.
CVGI offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
CVGI Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Under pressure | |
| Healthy |
CVGI's revenue and balance sheet are currently healthy, and its profitability is stable, but its cash flow is under pressure.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN's PE is in its cheap range at 22x, but its recent earnings include one-off gains. On analysts' estimates for next year's earnings, today's price would be 27x.
CVGI PE Valuation
CVGI has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 24x next year's earnings.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
CVGI Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect CVGI to return to profit, with revenue growing. However, they disagree widely on these estimates.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over CVGI on earnings quality, reporting a profit while its opponent remains loss making.
CVGI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.15 | — |
| Q3 2026 | -$0.32 | +$1.32 |
| Q2 2026 | -$0.67 | +$0.47 |
| Q1 2026 | -$0.52 | +$0.53 |
| Q4 2025 | -$0.67 | +$0.16 |
| Q3 2025 | -$1.64 | -262% |
| Q2 2025 | -$1.14 | -220% |
| Q1 2025 | -$1.05 | -181% |
| Q4 2024 | -$0.83 | -156% |
CVGI is still losing money, but far less than before: $0.32 per share over the past year, against $1.64 at its worst in late 2025.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over CVGI on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over CVGI on profitability, with a higher operating margin.
CVGI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $208.1M | +36% |
| Q2 2026 | $195.2M | +14% |
| Q1 2026 | $171.5M | +1% |
| Q4 2025 | $154.8M | -5.2% |
| Q3 2025 | $152.5M | -11% |
| Q2 2025 | $172M | -25% |
| Q1 2025 | $169.8M | -27% |
| Q4 2024 | $163.3M | -27% |
CVGI's revenue is recovering but still below its 2023 peak: $208M last quarter, up 36% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 3.7% | +4.4 points |
| Q2 2026 | 0.8% | +0.3 points |
| Q1 2026 | 8.6% | +7.8 points |
| Q4 2025 | -1.2% | +2.1 points |
| Q3 2025 | -0.7% | -0.1 points |
| Q2 2025 | 0.5% | +0.1 points |
| Q1 2025 | 0.8% | -2 points |
| Q4 2024 | -3.2% | -5.5 points |
CVGI's operating margin was 3.7% last quarter, up 4.4 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
CVGI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$3.5M | -$6K |
| Q2 2026 | -$1.4M | -108% |
| Q1 2026 | -$4.2M | -137% |
| Q4 2025 | $8.7M | +$39.3M |
| Q3 2025 | -$3.5M | +$16.8M |
| Q2 2025 | $17.4M | +173% |
| Q1 2025 | $11.4M | +$18.8M |
| Q4 2024 | -$30.6M | -908% |
CVGI has the edge over AMZN on cash flow, with more consistent year-over-year improvement.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has the edge over CVGI on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
CVGI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +13% | +4.4M shares |
| 1 year | +16% | +5.3M shares |
| 3 years | +17% | +5.8M shares |
| 5 years | +20% | +6.5M shares |
| Available history | +27% | +8.4M shares |
CVGI has 39M diluted shares, up 16% from a year ago.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN has the edge over CVGI on leverage, with a lower net debt burden relative to earnings.
CVGI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.5x | Healthy |
| Q2 2026 | 2.0x | Healthy |
| Q1 2026 | 2.4x | Moderate |
| Q4 2025 | 5.2x | High |
| Q3 2025 | 7.7x | High |
| Q2 2025 | 6.7x | High |
| Q1 2025 | 7.9x | High |
| Q4 2024 | 5.9x | High |
CVGI's net debt is about 1.5 years of its operating earnings (EBITDA), down from 7.7 years a year ago.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
CVGI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 35.2 | Neutral |
CVGI's weekly RSI is 51 (neutral) and its Stochastic is 35 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
CVGI PE vs Consumer Cyclical Sector
| Metric | CVGI | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
CVGI has no meaningful PE right now: it lost money over the past year.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over CVGI on trend strength, trading above more of its moving averages.
CVGI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.04 | 13% above |
| 20 week MA | $3.49 | 1.1% below |
| 50 week MA | $3.24 | 6.5% above |
| 100 week MA | $2.46 | 40% above |
| 200 week MA | $4.49 | 23% below |
CVGI's trend is mixed: it's above three of its five weekly moving averages, and 23% below its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has finished higher in five of the last six years, two of them by more than 50%. It's up 15% so far in 2026.
CVGI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $6.29 | $8.52 | +35% |
| 2021 | $8.52 | $7.55 | -11% |
| 2022 | $7.55 | $6.63 | -12% |
| 2023 | $6.63 | $7.01 | +5.7% |
| 2024 | $7.01 | $2.34 | -67% |
| 2025 | $2.34 | $1.50 | -36% |
| 2026 YTD | $1.50 | $3.45 | +130% |
CVGI has the edge over AMZN on returns for 2026, with the stronger performance.